Suchergebnisse - "Eggenhuizen, Peter"

PubPharm (60)

1

Clinical features and prognosis of ANCA-associated vasculitis patients who were double-seropositive for myeloperoxidase-ANCA and proteinase 3-ANCA

enthalten in: Clinical and experimental medicine | 2024

von Gong, Y. | Shen, C. | Meng, T. | +14

2

Clinical features and prognosis of ANCA-associated vasculitis patients who were double-seropositive for myeloperoxidase-ANCA and proteinase 3-ANCA

enthalten in: Clinical and experimental medicine | 2024

von Gong, Y. | Shen, C. | Meng, T. | +14

3

METHODS OF TREATMENT

enthalten in: Europäisches Patentamt | 2024

von OOI JOSHUA DANIEL | EGGENHUIZEN PETER JAMES | MORAND ERIC

4

The Influence of Cross-Reactive T Cells in COVID-19

enthalten in: Biomedicines | 2024

von Eggenhuizen, P. | Ooi, J.

5

Smith-specific regulatory T cells halt the progression of lupus nephritis

enthalten in: ResearchSquare.com | 2024

von Ooi, J. | Cheong, R. | Eggenhuizen, P. | +17

6

Smith-specific regulatory T cells halt the progression of lupus nephritis

enthalten in: Nature communications | 2024

von Eggenhuizen, P. | Cheong, R. | Lo, C. | +19

7

Single-cell transcriptomics uncover hub genes and cell-cell crosstalk in patients with hypertensive nephropathy

enthalten in: International immunopharmacology | 2023

von Tang, R. | Lin, W. | Shen, C. | +10

8

Sex disparities in clinicopathological features and outcomes of patients with myeloperoxidase-ANCA-associated vasculitis : a retrospective study of 366 cases in a single Chinese center

enthalten in: Clinical and experimental medicine | 2023

von Meng, T. | Zhu, P. | Shen, C. | +15

9

COMPOSITIONS AND METHODS FOR TREATING LUPUS

enthalten in: Europäisches Patentamt | 2023

von OOI JOSHUA | EGGENHUIZEN PETER | MORAND ERIC

10

COMPOSITIONS AND METHODS FOR TREATING LUPUS

enthalten in: Europäisches Patentamt | 2023

von OOI JOSHUA | EGGENHUIZEN PETER | MORAND ERIC

1
2
3
4
5
6
Nächster »
[6]